Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXH1RC
|
||||
| Drug Name |
3-Phenyl-propionic acid (2S,3S)-3-((S)-2-benzyloxycarbonylamino-3-phenyl-propionylamino)-4-oxo-azetidin-2-yl ester
|
||||
| Synonyms |
CHEMBL30356
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C29H29N3O6
|
||||
| Canonical SMILES |
O=C(CCc1ccccc1)O[C@@H]2NC(=O)[C@H]2NC(=O)[C@H](Cc3ccccc3)NC(=O)OCc4ccccc4
|
||||
| InChI |
InChI=1S/C29H29N3O6/c33-24(17-16-20-10-4-1-5-11-20)38-28-25(27(35)32-28)31-26(34)23(18-21-12-6-2-7-13-21)30-29(36)37-19-22-14-8-3-9-15-22/h1-15,23,25,28H,16-19H2,(H,30,36)(H,31,34)(H,32,35)/t23-,25+,28-/m0/s1
|
||||
| InChIKey |
YYTYMENWZQHVGX-CKOJHNACSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.